![Fulminant myocarditis: a comprehensive review from etiology to treatments and outcomes | Signal Transduction and Targeted Therapy Fulminant myocarditis: a comprehensive review from etiology to treatments and outcomes | Signal Transduction and Targeted Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41392-020-00360-y/MediaObjects/41392_2020_360_Fig3_HTML.png)
Fulminant myocarditis: a comprehensive review from etiology to treatments and outcomes | Signal Transduction and Targeted Therapy
![Fulminant myocarditis: a comprehensive review from etiology to treatments and outcomes | Signal Transduction and Targeted Therapy Fulminant myocarditis: a comprehensive review from etiology to treatments and outcomes | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-020-00360-y/MediaObjects/41392_2020_360_Figa_HTML.png)
Fulminant myocarditis: a comprehensive review from etiology to treatments and outcomes | Signal Transduction and Targeted Therapy
![AstraZeneca's diabetes drug Farxiga nabs coveted kidney disease nod, way ahead of rival Jardiance | Fierce Pharma AstraZeneca's diabetes drug Farxiga nabs coveted kidney disease nod, way ahead of rival Jardiance | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1619989374/Farxiga%2010mg.jpg?VersionId=dHWdb1WN.E.nqpjVWVnOqyBuZk7JIEKD)
AstraZeneca's diabetes drug Farxiga nabs coveted kidney disease nod, way ahead of rival Jardiance | Fierce Pharma
![Fulminant myocarditis: a comprehensive review from etiology to treatments and outcomes | Signal Transduction and Targeted Therapy Fulminant myocarditis: a comprehensive review from etiology to treatments and outcomes | Signal Transduction and Targeted Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41392-020-00360-y/MediaObjects/41392_2020_360_Fig6_HTML.png)